株探米国株
英語
エドガーで原本を確認する
6-K 1 q32023dolepressrelease.htm 6-K Document

6

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of November, 2023

Commission File Number 001-40695

Dole plc
(Exact name of registrant as specified in its charter)

29 North Anne Street
Dublin 7
D07 PH36
Ireland
(Address of Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
☒ Form 20-F ◻ Form 40-F On November 16, 2023, Dole plc (the "Company") will host a conference call and simultaneous webcast to discuss the Company's financial results for the three and nine months ended September 30, 2023.









An archived replay of the webcast and the investor presentation used during the webcast will be available shortly after the live event has concluded in the Investors section of the Company's website, www.doleplc.com/investors. A copy of the press release is furnished herewith as Exhibit 99.1 and incorporated by reference herein.



EXHIBIT INDEX

Exhibit No. Description











































DOLE PLC
SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: November 16, 2023
DOLE PLC
(Registrant)
By: /s/ Jacinta Devine
Name: Jacinta Devine
Title: Chief Financial Officer






































EX-99.1 2 doleplcreportsthirdquarter.htm EX-99.1 Document

Exhibit 99.1
Dole plc Reports Third Quarter 2023 Financial Results
DUBLIN – November 16, 2023 - Dole plc (NYSE: DOLE) ("Dole" or the "Group" or the "Company") today released its financial results for the three and nine months ended September 30, 2023.
Highlights for the three months ended September 30, 2023:
•Revenue of $2.0 billion, an increase of 4.2%
•Net Income of $54.0 million, an increase of 15.9%
•Adjusted EBITDA1 of $85.2 million, an increase of 7.6%
•Adjusted Net Income of $22.6 million and Adjusted Diluted EPS of $0.24
•Cash proceeds of $45.5 million related to asset sales
Financial Highlights - Unaudited
Three Months Ended
Nine Months Ended
September 30, 2023
September 30, 2022
September 30, 2023
September 30, 2022
(U.S. Dollars in millions, except per share amounts)
Revenue
2,043  1,961  6,173  5,982 
Income from continuing operations2 55.7  58.3  154.4  146.5 
Net Income 54.0  46.6  126.8  98.4 
Net Income attributable to Dole plc 45.3  39.8  101.7  79.7 
Diluted EPS from continuing operations 0.50  0.54  1.36  1.35 
Diluted EPS 0.48  0.42  1.07  0.84 
Adjusted EBITDA1
85.2  79.2  308.3  282.9 
Adjusted Net Income1
22.6  26.2  103.2  119.1 
Adjusted Diluted EPS1
0.24  0.28  1.09  1.25 

Commenting on the results, Carl McCann, Executive Chairman, said:

“We are very pleased that our momentum from the first half of the year has continued into the third quarter. We delivered another strong set of results, with Revenue growth of 4.2% and Adjusted EBITDA growth of 7.6%.
As we move towards the end of the financial year, our strong result for the first nine months positions us to deliver a good result for the year and we are now targeting Adjusted EBITDA for 2023 of at least $365.0 million.
Once again, we would like to extend our appreciation to all of our people across the Group for their dedication and efforts in delivering these results.”
1 Dole plc reports its financial results in accordance with U.S. Generally Accepted Accounting Principles ("GAAP"). See full GAAP financial results in the appendix. Adjusted EBIT, Adjusted EBITDA, Adjusted Net Income, Adjusted Earnings Per Share, Net Debt and Free Cash Flow from Continuing Operations are non-GAAP financial measures. Refer to the appendix of this release for an explanation and reconciliation of these and other non-GAAP financial measures used in this release to comparable GAAP financial measures.
2 Fresh Vegetables results are reported separately as discontinued operations, net of income taxes, in our condensed consolidated statements of operations, its assets and liabilities are separately presented in our condensed consolidated balance sheets, and its cash flows are presented separately in our condensed consolidated statements of cash flows for all periods presented. Unless otherwise noted, our discussion of our results included herein, outlook and all supplementary tables, including non-GAAP financial measures, are presented on a continuing operations basis.
1


Group Results - Third Quarter
Revenue increased 4.2%, or $82.0 million, primarily due to strong performance in the Diversified EMEA segment, offset partially by the Diversified Americas and Fresh Fruit segments. On a like-for-like basis3, revenue was 1.2%, or $23.6 million, ahead of prior year.
Adjusted EBITDA increased 7.6%, or $6.0 million, primarily driven by stronger performance in the Diversified Americas and Diversified EMEA segments. On a like-for-like basis, Adjusted EBITDA increased 4.2%, or $3.4 million.
Adjusted Net Income decreased $3.6 million, predominantly due to higher interest expense and tax expense, offset by the increases in Adjusted EBITDA as noted above and lower depreciation. Adjusted Diluted EPS for the three months ended September 30, 2023 was $0.24 compared to $0.28 in the prior year.

Selected Segmental Financial Information (Unaudited)
Three Months Ended
September 30, 2023
September 30, 2022
(U.S. Dollars in thousands)
Revenue Adjusted EBITDA Revenue Adjusted EBITDA
Fresh Fruit $ 749,210  $ 45,111  $ 751,348  $ 49,382 
Diversified Fresh Produce - EMEA 856,351  34,923  759,964  30,686 
Diversified Fresh Produce - Americas & ROW 470,011  5,159  479,839  (870)
Intersegment (32,900) —  (30,456) — 
Total $ 2,042,672  $ 85,193  $ 1,960,695  $ 79,198 
Nine Months Ended
September 30, 2023
September 30, 2022
(U.S. Dollars in thousands)
Revenue Adjusted EBITDA Revenue Adjusted EBITDA
Fresh Fruit $ 2,387,163  $ 180,138  $ 2,306,982  $ 166,087 
Diversified Fresh Produce - EMEA 2,570,080  100,932  2,400,967  88,397 
Diversified Fresh Produce - Americas & ROW 1,310,407  27,191  1,391,731  28,399 
Intersegment (94,637) —  (117,845) — 
Total $ 6,173,013  $ 308,261  $ 5,981,835  $ 282,883 
Fresh Fruit
Revenue decreased 0.3%, or $2.1 million. Revenue was negatively impacted by lower banana prices in North America, partially offset by higher worldwide volumes of bananas sold, an increase in worldwide pricing of pineapples and stronger pricing of bananas in Europe.
Adjusted EBITDA decreased 8.6%, or $4.3 million. Adjusted EBITDA was primarily impacted by lower revenue, higher fruit sourcing costs and a decrease in commercial cargo activity, partially offset by lower shipping and logistics costs, as well as by strong pricing excluding the impact of fuel surcharges.
Diversified Fresh Produce – EMEA
Revenue increased 12.7%, or $96.4 million, primarily driven by a favorable impact from foreign currency translation of $54.4 million, inflation-justified price increases across the segment and a positive impact from acquisitions of $5.5 million. On a like-for-like basis, revenue was 4.8%, or $36.5 million, ahead of prior year.
3 Like-for-like basis refers to the measure excluding the impact of foreign currency translation movements and acquisitions and divestitures.
2


Adjusted EBITDA increased 13.8%, or $4.2 million, primarily driven by a favorable impact from foreign currency translation of $2.0 million, an incremental positive impact from acquisitions of $0.2 million and strong performance in Ireland, the U.K., Spain and Holland. On a like-for-like basis, Adjusted EBITDA was 6.6%, or $2.0 million, ahead of prior year.
Diversified Fresh Produce – Americas & ROW
Revenue decreased 2.0%, or $9.8 million, primarily driven by lower revenue for berries in North America, as well as by lower volumes of most other commodities, partially offset by inflation-justified price increases.
Adjusted EBITDA increased 693.0%, or $6.0 million, primarily due to continued strong performance in most products that we market in North America, as well as by a favorable comparison to the three months ended September 2022, which had a challenging end to the Chilean grapes season due to abnormal supply chain disruption. These increases were partially offset by a challenging quarter for berries in North America.
Capital Expenditures
Capital expenditures for the nine months ended September 30, 2023 were $51.3 million, which included investments in farm renovations and ongoing investments in IT, logistics and efficiency projects in our warehouses and processing facilities. This amount only includes capital expenditures from continuing operations.
Sales of Assets
Sales of assets for the nine months ended September 30, 2023 were $64.1 million, compared to $27.8 million for the nine months ended September 30, 2022. These sales resulted in a gain on asset sales of $43.4 million for the nine months ended September 30, 2023, compared to $9.2 million for the nine months ended September 30, 2022. The increase was driven by $45.5 million of cash proceeds received during the three months ended September 30, 2023, resulting in a gain of $28.7 million. These proceeds were predominantly from the sale of idle land in Hawaii, which realized cash proceeds of $44.0 million.
Free Cash Flow from Continuing Operations and Net Debt
Free Cash Flow from Continuing Operations was $105.8 million for the nine months ended September 30, 2023. Free Cash Flow from Continuing Operations benefited from strong Adjusted EBITDA performance for the first nine months of the year and good working capital management across the Group. Net Debt as of September 30, 2023 was $0.9 billion.
Outlook for Fiscal Year 2023 (forward-looking statement)
We are very pleased with the Group’s performance in the first nine months of the year, delivering $308.3 million of Adjusted EBITDA.
While the wider macro-environment continues to remain complex and impacts from weather events remain unpredictable, we remain confident in the strength of our diversified supply base and the experience and quality of our operating teams across the globe to deal with challenges as they arise.
Overall, our strong results for the first nine months position us well to deliver a good result for the year and we are now targeting Adjusted EBITDA for 2023 of at least $365.0 million.
Dividend
On November 15, 2023, the Board of Directors of Dole plc declared a cash dividend for the third quarter of 2023 of $0.08 per share, payable on January 4, 2024 to shareholders of record on December 14, 2023. A cash dividend of $0.08 per share was paid on October 5, 2023 for the second quarter of 2023.
3


About Dole plc
A global leader in fresh produce, Dole plc produces, markets, and distributes an extensive variety of fresh fruits and vegetables sourced locally and from around the world. Dedicated and passionate in exceeding our customers’ requirements in over 75 countries, our goal is to make the world a healthier and a more sustainable place.
Webcast and Conference Call Information
Dole plc will host a conference call and simultaneous webcast at 08:00 a.m. Eastern Time today to discuss the third quarter 2023 financial results. The webcast can be accessed at www.doleplc.com/investor-relations
The conference call can be accessed live by dialing (646) 307-1963 in the US or +353 (1) 582 2023 in Ireland and +44 20 3481 4247 for UK and other international participants. The conference ID is 6406315.
Forward-looking information
Certain statements made in this press release that are not historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are based on management’s beliefs, assumptions, and expectations of our future economic performance, considering the information currently available to management. These statements are not statements of historical fact. The words “believe,” “may,” “could,” “will,” “should,” “would,” “anticipate,” “estimate,” “expect,” “intend,” “objective,” “seek,” “strive,” “target” or similar words, or the negative of these words, identify forward-looking statements. The inclusion of this forward-looking information should not be regarded as a representation by us or any other person that the future plans, estimates, or expectations contemplated by us will be achieved. Such forward-looking statements are subject to various risks and uncertainties and assumptions relating to our operations, financial results, financial condition, business prospects, growth strategy and liquidity. Accordingly, there are, or will be, important factors that could cause our actual results to differ materially from those indicated in these statements. If one or more of these or other risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, our actual results may vary materially from what we may have expressed or implied by these forward-looking statements. We caution that you should not place undue reliance on any of our forward-looking statements. Any forward-looking statement speaks only as of the date on which such statement is made, and we do not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made except as required by the federal securities laws.
Investor Contact:
James O'Regan, Head of Investor Relations, Dole plc
joregan@totalproduce.com
+353 1 887 2794
Media Contact:
Brian Bell, Ogilvy
brian.bell@ogilvy.com
+353 87 2436 130
4


Appendix
Consolidated Statement of Operations - Unaudited
Three Months Ended Nine Months Ended
September 30, 2023
September 30, 2022
September 30, 2023 September 30, 2022
(U.S. Dollars and shares in thousands, except per share amounts)
Revenues, net $ 2,042,672  $ 1,960,695  $ 6,173,013  $ 5,981,835 
Cost of sales (1,876,292) (1,829,233) (5,631,021) (5,533,069)
Gross profit 166,380  131,462  541,992  448,766 
Selling, marketing, general and administrative expenses (118,023) (103,349) (354,569) (323,258)
Gain on disposal of businesses —  —  —  242 
Gain on asset sales 28,746  767  43,442  9,188 
Operating income 77,103  28,880  230,865  134,938 
Other income, net 4,817  9,199  7,721  19,765 
Interest income 2,311  1,427  7,260  4,421 
Interest expense (20,899) (15,677) (62,359) (38,126)
Income from continuing operations before income taxes and equity earnings 63,332  23,829  183,487  120,998 
Income tax (expense) benefit (13,017) 34,155  (40,604) 21,497 
Equity method earnings 5,342  300  11,508  4,028 
Income from continuing operations 55,657  58,284  154,391  146,523 
Loss from discontinued operations, net of income taxes (1,672) (11,704) (27,616) (48,129)
Net income 53,985  46,580  126,775  98,394 
Less: Net income attributable to noncontrolling interests (8,693) (6,743) (25,049) (18,679)
Net income attributable to Dole plc $ 45,292  $ 39,837  $ 101,726  $ 79,715 
Income (loss) per share - basic:
Continuing operations $ 0.50  $ 0.54  $ 1.36  $ 1.35 
Discontinued operations (0.02) (0.12) (0.29) (0.51)
Net income per share attributable to Dole plc - basic $ 0.48  $ 0.42  $ 1.07  $ 0.84 
Income (loss) per share - diluted:
Continuing operations $ 0.50  $ 0.54  $ 1.36  $ 1.35 
Discontinued operations (0.02) (0.12) (0.29) (0.51)
Net income per share attributable to Dole plc - diluted $ 0.48  $ 0.42  $ 1.07  $ 0.84 
Weighted-average shares:
Basic 94,929  94,891  94,912  94,882 
Diluted 95,148  94,908  95,094  94,910 











5


Consolidated Balance Sheets - Unaudited
September 30, 2023
December 31, 2022
ASSETS (U.S. Dollars and shares in thousands)
Cash and cash equivalents $ 217,523  $ 228,840 
Short-term investments 5,735  5,367 
Trade receivables, net of allowances for credit losses of $22,498 and $18,001, respectively 575,205  610,384 
Grower advance receivables, net of allowances for credit losses of $20,946 and $15,817, respectively 124,981  106,864 
Other receivables, net of allowances for credit losses of $13,733 and $14,538, respectively 114,513  132,947 
Inventories, net of allowances of $3,889 and $4,186, respectively 366,718  394,150 
Prepaid expenses 59,709  48,995 
Other current assets 33,303  15,034 
Fresh Vegetables current assets held for sale 414,222  62,252 
Other assets held for sale 10,318  645 
Total current assets 1,922,227  1,605,478 
Long-term investments 15,468  16,498 
Investments in unconsolidated affiliates 127,429  124,234 
Actively marketed property 13,781  31,007 
Property, plant and equipment, net of accumulated depreciation of $414,698 and $375,721, respectively 1,085,778  1,116,124 
Operating lease right-of-use assets 312,608  293,658 
Goodwill 500,892  497,453 
DOLE brand 306,280  306,280 
Other intangible assets, net of accumulated amortization of $127,462 and $120,315, respectively 43,351  50,990 
Fresh Vegetables non-current assets held for sale —  343,828 
Other assets 139,598  142,180 
Deferred tax assets, net 70,263  64,112 
Total assets $ 4,537,675  $ 4,591,842 
LIABILITIES AND EQUITY
Accounts payable $ 619,914  $ 640,620 
Income taxes payable 33,773  11,558 
Accrued liabilities 380,196  381,688 
Bank overdrafts 13,772  8,623 
Current portion of long-term debt, net 255,953  97,435 
Current maturities of operating leases 59,702  57,372 
Payroll and other tax 23,811  27,187 
Contingent consideration 663  1,791 
Pension and other postretirement benefits 15,878  17,287 
Fresh Vegetables current liabilities held for sale 294,588  199,255 
Dividends payable and other current liabilities 21,994  17,698 
Total current liabilities 1,720,244  1,460,514 
Long-term debt, net 859,677  1,127,321 
Operating leases, less current maturities 262,160  246,723 
Deferred tax liabilities, net 112,333  118,403 
Income taxes payable, less current portion 16,921  30,458 
Contingent consideration, less current portion 7,542  5,022 
Pension and other postretirement benefits, less current portion 117,946  124,646 
Fresh Vegetables non-current liabilities held for sale —  116,380 
Other long-term liabilities 43,906  43,390 
Total liabilities $ 3,140,729  $ 3,272,857 
Redeemable noncontrolling interests 34,182  32,311 
Stockholders’ equity:
Common stock — $0.01 par value; 300,000 shares authorized and 94,929 and 94,899 shares outstanding as of September 30, 2023 and December 31, 2022 949  949 
Additional paid-in capital 796,290  795,063 
Retained earnings 547,912  469,249 
Accumulated other comprehensive loss (112,967) (104,133)
Total equity attributable to Dole plc 1,232,184  1,161,128 
Equity attributable to noncontrolling interests 130,580  125,546 
Total equity 1,362,764  1,286,674 
Total liabilities, redeemable noncontrolling interests and equity $ 4,537,675  $ 4,591,842 
6



Consolidated Statements of Cash Flows - Unaudited
Nine Months Ended
September 30, 2023 September 30, 2022
Operating Activities (U.S. Dollars in thousands)
Net income $ 126,775  $ 98,394 
Loss from discontinued operations, net of taxes 27,616  48,129 
Income from continuing operations 154,391  146,523 
Adjustments to reconcile income from continuing operations to net cash provided by operating activities - continuing operations:
Depreciation and amortization 76,908  81,792 
Incremental charges on biological assets related to the acquisition of Legacy Dole —  40,464 
Net (gain) on sale of assets and asset write-offs (43,506) (9,188)
Stock-based compensation expense 4,381  3,118 
Equity method earnings (11,508) (4,028)
Amortization of debt discounts and debt issuance costs 4,788  4,546 
Deferred tax (benefit) (11,747) (12,537)
Pension and other postretirement benefit plan expense 4,160  482 
Dividends received from equity method investments 6,350  7,632 
Other (6,118) (2,277)
Changes in operating assets and liabilities:
Receivables, net of allowances 13,858  (9,494)
Inventories 26,642  (52,022)
Prepaids, accrued and other current and long-term assets and liabilities (61,465) (11,935)
Net cash provided by operating activities - continuing operations 157,134  183,076 
Investing activities
Sales of assets 64,103  27,764 
Capital expenditures (51,334) (58,555)
Acquisitions, net of cash acquired (262) (4,886)
Insurance proceeds 1,850  2,278 
Purchases of investments (1,153) (414)
Sales (purchases) of unconsolidated affiliates 1,498  (801)
Other (127) 25 
Net cash provided by (used in) investing activities - continuing operations 14,575  (34,589)
Financing activities
Proceeds from borrowings and overdrafts 1,190,596  1,008,423 
Repayments on borrowings and overdrafts (1,300,083) (1,050,928)
Payment of debt issuance costs —  (265)
Dividends paid to shareholders (22,873) (22,770)
Dividends paid to noncontrolling interests (24,824) (20,981)
Other noncontrolling interest activity, net (482) — 
Payment of contingent consideration (1,169) (2,451)
Net cash used in financing activities - continuing operations (158,835) (88,972)
Effect of foreign exchange rate changes on cash (1,716) (19,052)
Net cash used in operating activities - discontinued operations (15,772) (61,521)
Net cash used in investing activities - discontinued operations (6,703) (8,027)
Cash used in discontinued operations, net (22,475) (69,548)
(Decrease) in cash and cash equivalents (11,317) (29,085)
Cash and cash equivalents at beginning of period 228,840  250,561 
Cash and cash equivalents at end of period $ 217,523  $ 221,476 
Supplemental cash flow information:
Income tax payments, net of refunds $ (49,142) $ (39,628)
Interest payments on borrowings $ (62,771) $ (39,703)
7


Reconciliation from Net Income to Adjusted EBITDA - Unaudited
The following information is provided to give quantitative information related to items impacting comparability. Refer to the 'Non-GAAP Financial Measures' section of this document for additional detail on each item.

Three Months Ended Nine Months Ended
September 30, 2023 September 30, 2022 September 30, 2023 September 30, 2022
(U.S. Dollars in thousands)
Net income (Reported GAAP) $ 53,985  $ 46,580  $ 126,775  $ 98,394 
Loss from discontinued operations, net of income taxes 1,672  11,704  27,616  48,129 
Income from continuing operations (Reported GAAP) 55,657  58,284  154,391  146,523 
Income tax expense (benefit) 13,017  (34,155) 40,604  (21,497)
Interest expense 20,899  15,677  62,359  38,126 
Mark to market (gains) losses (4,783) 2,310  (2,926) (5,819)
(Gain) on asset sales (28,802) (530) (43,356) (8,346)
Incremental charges on biological assets related to the acquisition of Legacy Dole —  5,520  —  40,464 
Cyber-related incident —  —  5,321  — 
Other items4 222  (532) 1,085  (1,284)
Adjustments from equity method investments 2,160  1,603  6,405  4,926 
Adjusted EBIT (Non-GAAP) 58,370  48,177  223,883  193,093 
Depreciation 21,737  25,315  69,182  73,544 
Amortization of intangible assets 2,536  2,633  7,726  8,248 
Depreciation and amortization adjustments from equity method investments 2,550  3,073  7,470  7,998 
Adjusted EBITDA (Non-GAAP) $ 85,193  $ 79,198  $ 308,261  $ 282,883 












4 For the three months ended September 30, 2023, other items is primarily comprised of $0.2 million of asset writedowns, net of insurance proceeds. For the three months ended September 30, 2022, other items is primarily comprised of $1.0 million in legal cost adjustments, partially offset by $0.5 million of asset writedowns, net of insurance proceeds. For the nine months ended September 30, 2023, other items is primarily comprised of $1.1 million of asset writedowns, net of insurance proceeds. For the nine months ended September 30, 2022, other items is primarily comprised of $1.0 million in legal cost adjustments and $0.3 million in gains on disposal of a business.
8


Reconciliation from Net Income attributable to Dole plc to Adjusted Net Income - Unaudited
The following information is provided to give quantitative information related to items impacting comparability. Refer to the 'Non-GAAP Financial Measures' section of this document for additional detail on each item. Refer to the Appendix for supplementary detail.

Three Months Ended Nine Months Ended
September 30, 2023 September 30, 2022 September 30, 2023 September 30, 2022
(U.S. Dollars and shares in thousands, except per share amounts)
Net income attributable to Dole plc (Reported GAAP) $ 45,292  $ 39,837  $ 101,726  $ 79,715 
Loss from discontinued operations, net of income taxes 1,672  11,704  27,616  48,129 
Income from continuing operations attributable to Dole plc 46,964  51,541  129,342  127,844 
Adjustments:
Amortization of intangible assets 2,536  2,633  7,726  8,248 
Mark to market (gains) losses (4,783) 2,310  (2,926) (5,819)
(Gain) on asset sales (28,802) (530) (43,356) (8,346)
Incremental charges on biological assets related to the acquisition of Legacy Dole —  5,520  —  40,464 
Cyber-related incident —  —  5,321  — 
Other items5 222  (532) 1,085  (1,284)
Adjustments from equity method investments 610  628  1,352  1,918 
Income tax on items above and discrete tax items 6,464  (34,501) 6,952  (41,628)
NCI impact on items above (645) (878) (2,274) (2,289)
Adjusted Net Income for Adjusted EPS calculation (Non-GAAP) $ 22,566  $ 26,191  $ 103,222  $ 119,108 
Adjusted earnings per share – basic (Non-GAAP) $ 0.24  $ 0.28  $ 1.09  $ 1.26 
Adjusted earnings per share – diluted (Non-GAAP) $ 0.24  $ 0.28  $ 1.09  $ 1.25 
Weighted average shares outstanding – basic 94,929  94,891  94,912  94,882 
Weighted average shares outstanding – diluted 95,148  94,908  95,094  94,910 
    


5 For the three months ended September 30, 2023, other items is primarily comprised of $0.2 million of asset writedowns, net of insurance proceeds. For the three months ended September 30, 2022, other items is primarily comprised of $1.0 million in legal cost adjustments, partially offset by $0.5 million of asset writedowns, net of insurance proceeds. For the nine months ended September 30, 2023, other items is primarily comprised of $1.1 million of asset writedowns, net of insurance proceeds. For the nine months ended September 30, 2022, other items is primarily comprised of $1.0 million in legal cost adjustments and $0.3 million in gains on disposal of a business.
9


Supplemental Reconciliation from Net Income attributable to Dole plc to Adjusted Net Income - Unaudited
The following information is provided to give quantitative information related to items impacting comparability. Refer to the 'Non-GAAP Financial Measures' section of this document for additional detail on each item.
Three Months Ended September 30, 2023
(U.S. Dollars in thousands)
Revenues, net Cost of sales Gross profit Gross Margin % Selling, marketing, general and administrative expenses Other operating charges6 Operating Income
Reported (GAAP) $ 2,042,672  (1,876,292) 166,380  8.1  % (118,023) 28,746  $ 77,103 
Loss from discontinued operations, net of income taxes —  —  —  —  —  — 
Amortization of intangible assets —  —  —  2,536  —  2,536 
Mark to market (gains) losses —  (1,113) (1,113) —  —  (1,113)
(Gain) on asset sales —  —  —  —  (28,802) (28,802)
Cyber-related incident —  —  —  —  —  — 
Other items —  222  222  —  —  222 
Adjustments from equity method investments —  —  —  —  —  — 
Income tax on items above and discrete tax items —  —  —  —  —  — 
NCI impact on items above —  —  —  —  —  — 
Adjusted (Non-GAAP) $ 2,042,672  (1,877,183) 165,489  8.1  % (115,487) (56) $ 49,946 
Three Months Ended September 30, 2022
(U.S. Dollars in thousands)
Revenues, net Cost of sales Gross profit Gross Margin % Selling, marketing, general and administrative expenses
Other operating charges7
Operating Income
Reported (GAAP) $ 1,960,695  (1,829,233) 131,462  6.7  % (103,349) 767  $ 28,880 
Loss from discontinued operations, net of income taxes —  —  —  —  —  — 
Amortization of intangible assets —  —  —  2,633  —  2,633 
Mark to market (gains) losses —  7,729  7,729  —  —  7,729 
(Gain) on asset sales —  —  —  —  (530) (530)
Incremental charges on biological assets related to the acquisition of Legacy Dole —  5,520  5,520  —  —  5,520 
Other items —  509  509  (1,041) —  (532)
Adjustments from equity method investments —  —  —  —  —  — 
Income tax on items above and discrete tax items —  —  —  —  —  — 
NCI impact on items above —  —  —  —  —  — 
Adjusted (Non-GAAP) $ 1,960,695  (1,815,475) 145,220  7.4  % (101,757) 237  $ 43,700 
6 Other operating charges for the three months ended September 30, 2023 is comprised of gains on asset sales of $28.7 million, as reported on the Dole plc GAAP Consolidated Statements of Operations.
7 Other operating charges for the three months ended September 30, 2022 is comprised of gains on asset sales of $0.8 million, as reported on the Dole plc the GAAP Consolidated Statements of Operations.
10


Three Months Ended September 30, 2023
(U.S. Dollars in thousands)
Other income, net Interest income Interest expense Income tax expense Equity method earnings Income from continuing operations Loss from discontinued operations, net of income taxes
Reported (GAAP) $ 4,817  2,311  (20,899) (13,017) 5,342  55,657  $ (1,672)
Loss from discontinued operations, net of income taxes —  —  —  —  —  —  1,672 
Amortization of intangible assets —  —  —  —  —  2,536  — 
Mark to market (gains) losses (3,670) —  —  —  —  (4,783) — 
(Gain) on asset sales —  —  —  —  —  (28,802) — 
Cyber-related incident —  —  —  —  —  —  — 
Other items —  —  —  —  —  222  — 
Adjustments from equity method investments —  —  —  —  610  610  — 
Income tax on items above and discrete tax items —  —  —  6,603  (139) 6,464  — 
NCI impact on items above —  —  —  —  —  —  — 
Adjusted (Non-GAAP) $ 1,147  2,311  (20,899) (6,414) 5,813  31,904  $ — 

Three Months Ended September 30, 2022
(U.S. Dollars in thousands)
Other income, net Interest income Interest expense Income tax benefit (expense) Equity method earnings Income from continuing operations Loss from discontinued operations, net of income taxes
Reported (GAAP) $ 9,199  1,427  (15,677) 34,155  300  58,284  $ (11,704)
Loss from discontinued operations, net of income taxes —  —  —  —  —  —  11,704 
Amortization of intangible assets —  —  —  —  —  2,633  — 
Mark to market (gains) losses (5,419) —  —  —  —  2,310  — 
(Gain) on asset sales —  —  —  —  —  (530) — 
Incremental charges on biological assets related to the acquisition of Legacy Dole —  —  —  —  —  5,520  — 
Other items —  —  —  —  —  (532) — 
Adjustments from equity method investments —  —  —  —  628  628  — 
Income tax on items above and discrete tax items —  —  —  (34,400) (101) (34,501) — 
NCI impact on items above —  —  —  —  —  —  — 
Adjusted (Non-GAAP) $ 3,780  1,427  (15,677) (245) 827  33,812  $ — 



11


Three Months Ended September 30, 2023
(U.S. Dollars and shares in thousands, except per share amounts)
Net income Net income attributable to noncontrolling interests Net income attributable to Dole plc Diluted net income per share
Reported (GAAP) $ 53,985  $ (8,693) $ 45,292  $ 0.48 
Loss from discontinued operations, net of income taxes 1,672  —  1,672 
Amortization of intangible assets 2,536  —  2,536 
Mark to market (gains) losses (4,783) —  (4,783)
(Gain) on asset sales (28,802) —  (28,802)
Cyber-related incident —  —  — 
Other items 222  —  222 
Adjustments from equity method investments 610  —  610 
Income tax on items above and discrete tax items 6,464  —  6,464 
NCI impact on items above —  (645) (645)
Adjusted (Non-GAAP) $ 31,904  $ (9,338) $ 22,566  $ 0.24 
Weighted average shares outstanding – diluted 95,148 
Three Months Ended September 30, 2022
(U.S. Dollars and shares in thousands, except per share amounts)
Net income Net income attributable to noncontrolling interests Net income attributable to Dole plc Diluted net income per share
Reported (GAAP) $ 46,580  $ (6,743) $ 39,837  $ 0.42 
Loss from discontinued operations, net of income taxes 11,704  —  11,704 
Amortization of intangible assets 2,633  —  2,633 
Mark to market (gains) losses 2,310  —  2,310 
(Gain) on asset sales (530) —  (530)
Incremental charges on biological assets related to the acquisition of Legacy Dole 5,520  —  5,520 
Other items (532) —  (532)
Adjustments from equity method investments 628  —  628 
Income tax on items above and discrete tax items (34,501) —  (34,501)
NCI impact on items above —  (878) (878)
Adjusted (Non-GAAP) $ 33,812  $ (7,621) $ 26,191  $ 0.28 
Weighted average shares outstanding – diluted 94,908 


12


Supplemental Reconciliation from Net Income attributable to Dole plc to Adjusted Net Income - Unaudited
The following information is provided to give quantitative information related to items impacting comparability. Refer to the 'Non-GAAP Financial Measures' section of this document for additional detail on each item.
Nine Months Ended September 30, 2023
(U.S. Dollars in thousands)
Revenues, net Cost of sales Gross profit Gross Margin % Selling, marketing, general and administrative expenses Other operating charges8 Operating Income
Reported (GAAP) $ 6,173,013  (5,631,021) 541,992  8.8  % (354,569) 43,442  $ 230,865 
Loss from discontinued operations, net of income taxes —  —  —  —  —  — 
Amortization of intangible assets —  —  —  7,726  —  7,726 
Mark to market (gains) losses —  (2,449) (2,449) —  —  (2,449)
(Gain) on asset sales —  —  —  —  (43,356) (43,356)
Cyber-related incident —  —  —  5,321  —  5,321 
Other items —  1,085  1,085  —  —  1,085 
Adjustments from equity method investments —  —  —  —  —  — 
Income tax on items above and discrete tax items —  —  —  —  —  — 
NCI impact on items above —  —  —  —  —  — 
Adjusted (Non-GAAP) $ 6,173,013  (5,632,385) 540,628  8.8  % (341,522) 86  $ 199,192 
Nine Months Ended September 30, 2022
(U.S. Dollars in thousands)
Revenues, net Cost of sales Gross profit Gross Margin % Selling, marketing, general and administrative expenses
Other operating charges9
Operating Income
Reported (GAAP) $ 5,981,835  (5,533,069) 448,766  7.5  % (323,258) 9,430  $ 134,938 
Loss from discontinued operations, net of income taxes —  —  —  —  —  — 
Amortization of intangible assets —  —  —  8,248  —  8,248 
Mark to market (gains) losses —  2,372  2,372  —  —  2,372 
(Gain) on asset sales —  —  —  —  (8,346) (8,346)
Incremental charges on biological assets related to the acquisition of Legacy Dole —  40,464  40,464  —  —  40,464 
Other items —  —  —  (1,015) (269) (1,284)
Adjustments from equity method investments —  —  —  —  —  — 
Income tax on items above and discrete tax items —  —  —  —  —  — 
NCI impact on items above —  —  —  —  —  — 
Adjusted (Non-GAAP) $ 5,981,835  (5,490,233) 491,602  8.2  % (316,025) 815  $ 176,392 
8 Other operating charges for the six months ended September 30, 2023 is comprised of gains on asset sales of $43.4 million, as reported on the Dole plc GAAP Consolidated Statements of Operations.
9 Other operating charges for the nine months ended September 30, 2022 is comprised of gains on asset sales of $9.2 million and a gain on disposal of businesses of $0.2 million, as reported on the Dole plc GAAP Consolidated Statements of Operations.
13


Nine Months Ended September 30, 2023
(U.S. Dollars in thousands)
Other income, net Interest income Interest expense Income tax expense Equity method earnings Income from continuing operations Loss from discontinued operations, net of income taxes
Reported (GAAP) $ 7,721  7,260  (62,359) (40,604) 11,508  154,391  $ (27,616)
Loss from discontinued operations, net of income taxes —  —  —  —  —  —  27,616 
Amortization of intangible assets —  —  —  —  —  7,726  — 
Mark to market (gains) losses (477) —  —  —  —  (2,926) — 
(Gain) on asset sales —  —  —  —  —  (43,356) — 
Cyber-related incident —  —  —  —  —  5,321  — 
Other items —  —  —  —  —  1,085  — 
Adjustments from equity method investments —  —  —  —  1,352  1,352  — 
Income tax on items above and discrete tax items —  —  —  7,253  (301) 6,952  — 
NCI impact on items above —  —  —  —  —  —  — 
Adjusted (Non-GAAP) $ 7,244  7,260  (62,359) (33,351) 12,559  130,545  $ — 

Nine Months Ended September 30, 2022
(U.S. Dollars in thousands)
Other income, net Interest income Interest expense Income tax benefit (expense) Equity method earnings Income from continuing operations Loss from discontinued operations, net of income taxes
Reported (GAAP) $ 19,765  4,421  (38,126) 21,497  4,028  146,523  $ (48,129)
Loss from discontinued operations, net of income taxes —  —  —  —  —  —  48,129 
Amortization of intangible assets —  —  —  —  —  8,248  — 
Mark to market (gains) losses (8,191) —  —  —  —  (5,819) — 
(Gain) on asset sales —  —  —  —  —  (8,346) — 
Incremental charges on biological assets related to the acquisition of Legacy Dole —  —  —  —  —  40,464  — 
Other items —  —  —  —  —  (1,284) — 
Adjustments from equity method investments —  —  —  —  1,918  1,918  — 
Income tax on items above and discrete tax items —  —  —  (41,320) (308) (41,628) — 
NCI impact on items above —  —  —  —  —  —  — 
Adjusted (Non-GAAP) $ 11,574  4,421  (38,126) (19,823) 5,638  140,076  $ — 



14


Nine Months Ended September 30, 2023
(U.S. Dollars and shares in thousands, except per share amounts)
Net income Net income attributable to noncontrolling interests Net income attributable to Dole plc Diluted net income per share
Reported (GAAP) $ 126,775  $ (25,049) $ 101,726  $ 1.07 
Loss from discontinued operations, net of income taxes 27,616  —  27,616 
Amortization of intangible assets 7,726  —  7,726 
Mark to market (gains) losses (2,926) —  (2,926)
(Gain) on asset sales (43,356) —  (43,356)
Cyber-related incident 5,321  —  5,321 
Other items 1,085  —  1,085 
Adjustments from equity method investments 1,352  —  1,352 
Income tax on items above and discrete tax items 6,952  —  6,952 
NCI impact on items above —  (2,274) (2,274)
Adjusted (Non-GAAP) $ 130,545  $ (27,323) $ 103,222  $ 1.09 
Weighted average shares outstanding – diluted 95,094 
Nine Months Ended September 30, 2022
(U.S. Dollars and shares in thousands, except per share amounts)
Net income Net income attributable to noncontrolling interests Net income attributable to Dole plc Diluted net income per share
Reported (GAAP) $ 98,394  $ (18,679) $ 79,715  $ 0.84 
Loss from discontinued operations, net of income taxes 48,129  —  48,129 
Amortization of intangible assets 8,248  —  8,248 
Mark to market (gains) losses (5,819) —  (5,819)
(Gain) on asset sales (8,346) —  (8,346)
Incremental charges on biological assets related to the acquisition of Legacy Dole 40,464  —  40,464 
Other items (1,284) —  (1,284)
Adjustments from equity method investments 1,918  —  1,918 
Income tax on items above and discrete tax items (41,628) —  (41,628)
NCI impact on items above —  (2,289) (2,289)
Adjusted (Non-GAAP) $ 140,076  $ (20,968) $ 119,108  $ 1.25 
Weighted average shares outstanding – diluted 94,910 


15


Supplemental Reconciliation of Prior Year Segment Results to Current Year Segment Results – Unaudited
Revenue for the Three Months Ended
September 30, 2022 Impact of Foreign Currency Translation Impact of Acquisitions and Divestitures Like-for-like Increase (Decrease) September 30, 2023
(U.S. Dollars in thousands)
Fresh Fruit $ 751,348  $ —  $ —  $ (2,138) $ 749,210 
Diversified Fresh Produce - EMEA 759,964  54,373  5,540  36,474  856,351 
Diversified Fresh Produce - Americas & ROW 479,839  (1,491) —  (8,337) 470,011 
Intersegment (30,456) —  —  (2,444) (32,900)
Total $ 1,960,695  $ 52,882  $ 5,540  $ 23,555  $ 2,042,672 
Adjusted EBITDA for the Three Months Ended
September 30, 2022 Impact of Foreign Currency Translation Impact of Acquisitions and Divestitures Like-for-like Increase (Decrease) September 30, 2023
(U.S. Dollars in thousands)
Fresh Fruit $ 49,382  $ (375) $ —  $ (3,896) $ 45,111 
Diversified Fresh Produce - EMEA 30,686  2,013  187  2,037  34,923 
Diversified Fresh Produce - Americas & ROW (870) (115) 932  5,212  5,159 
Total $ 79,198  $ 1,523  $ 1,119  $ 3,353  $ 85,193 
Revenue for the Nine Months Ended
September 30, 2022 Impact of Foreign Currency Translation Impact of Acquisitions and Divestitures Like-for-like Increase (Decrease) September 30, 2023
(U.S. Dollars in thousands)
Fresh Fruit $ 2,306,982  $ —  $ —  $ 80,181  $ 2,387,163 
Diversified Fresh Produce - EMEA 2,400,967  (188) 23,642  145,659  2,570,080 
Diversified Fresh Produce - Americas & ROW 1,391,731  (6,524) —  (74,800) 1,310,407 
Intersegment (117,845) —  —  23,208  (94,637)
Total $ 5,981,835  $ (6,712) $ 23,642  $ 174,248  $ 6,173,013 
Adjusted EBITDA for the Nine Months Ended
September 30, 2022 Impact of Foreign Currency Translation Impact of Acquisitions and Divestitures Like-for-like Increase (Decrease) September 30, 2023
(U.S. Dollars in thousands)
Fresh Fruit $ 166,087  $ (330) $ —  $ 14,381  $ 180,138 
Diversified Fresh Produce - EMEA 88,397  212  1,458  10,865  100,932 
Diversified Fresh Produce - Americas & ROW 28,399  (245) 1,498  (2,461) 27,191 
Total $ 282,883  $ (363) $ 2,956  $ 22,785  $ 308,261 
16


Net Debt Reconciliation
Net Debt is the primary measure used by management to analyze the Company’s capital structure. Net Debt is a non-GAAP financial measure, calculated as cash and cash equivalents, less current and long-term debt. It also excludes debt discounts and debt issuance costs. The calculation of Net Debt as of September 30, 2023 is presented below. Net Debt as of September 30, 2023 was $0.9 billion.
September 30, 2023
December 31, 2022
(U.S. Dollars in thousands)
Cash and cash equivalents (Reported GAAP) 217,523  228,840 
Debt (Reported GAAP):
Long-term debt, net (859,677) (1,127,321)
Current maturities (255,953) (97,435)
Bank overdrafts (13,772) (8,623)
Total debt, net (1,129,402) (1,233,379)
Less: Debt discounts and debt issuance costs (Reported GAAP) (15,233) (17,874)
Total gross debt (1,144,635) (1,251,253)
Net Debt (Non-GAAP)
$ (927,112) $ (1,022,413)

Free Cash Flow from Continuing Operations Reconciliation

Nine Months Ended
September 30, 2023
September 30, 2022
(U.S. Dollars in thousands)
Net cash provided by operating activities - continuing operations (Reported GAAP) 157,134  183,076 
Less: Capital expenditures (Reported GAAP)10 (51,334) (58,555)
Free cash flow from continuing operations (Non-GAAP)
$ 105,800  $ 124,521 
10 Capital expenditures do not include amounts attributable to discontinued operations.
17


Supplemental Consolidated Income Statement by Quarter - for the Year Ended December 31, 2022 - Unaudited

Three Months Ended Year Ended
March 31,
2022
June 30,
2022
September 30,
2022
December 31,
2022
December 31,
2022
(U.S. Dollars and shares in thousands, except per share amounts)
Revenues, net $ 1,970,231  $ 2,050,909  $ 1,960,695  $ 2,042,568  $ 8,024,403 
Cost of sales (1,818,436) (1,885,400) (1,829,233) (1,891,456) (7,424,525)
Gross profit 151,795  165,509  131,462  151,112  599,878 
Selling, marketing, general and administrative expenses (109,544) (110,365) (103,349) (112,934) (436,192)
Gain (loss) on disposal of businesses 242  —  —  (50) 192 
Impairment of property, plant and equipment —  —  —  (397) (397)
Gain on asset sales 495  7,926  767  2,596  11,784 
Operating income 42,988  63,070  28,880  40,327  175,265 
Other income (expense), net 2,464  8,102  9,199  (9,165) 10,600 
Interest income 1,584  1,410  1,427  1,986  6,407 
Interest expense (11,616) (10,833) (15,677) (18,245) (56,371)
Income from continuing operations before income taxes and equity earnings 35,420  61,749  23,829  14,903  135,901 
Income tax (expense) benefit (7,358) (5,300) 34,155  4,106  25,603 
Equity method earnings 577  3,151  300  2,698  6,726 
Income from continuing operations 28,639  59,600  58,284  21,707  168,230 
Loss from discontinued operations, net of income taxes (25,230) (11,195) (11,704) (8,318) (56,447)
Net income 3,409  48,405  46,580  13,389  111,783 
Less: Net income attributable to noncontrolling interests (4,803) (7,133) (6,743) (6,608) (25,287)
Net (loss) income attributable to Dole plc $ (1,394) $ 41,272  $ 39,837  $ 6,781  $ 86,496 
Income (loss) per share - basic:
Continuing operations $ 0.26  $ 0.55  $ 0.54  $ 0.16  $ 1.51 
Discontinued operations (0.27) (0.12) (0.12) (0.09) (0.60)
Net income (loss) per share attributable to Dole plc - basic $ (0.01) $ 0.43  $ 0.42  $ 0.07  $ 0.91 
Income (loss) per share - diluted:
Continuing operations $ 0.26  $ 0.55  $ 0.54  $ 0.16  $ 1.51 
Discontinued operations (0.27) (0.12) (0.12) (0.09) (0.60)
Net income (loss) per share attributable to Dole plc - diluted $ (0.01) $ 0.43  $ 0.42  $ 0.07  $ 0.91 
Weighted-average shares:
Basic 94,878  94,878  94,891  94,899  94,886 
Diluted 94,909  94,913  94,908  94,928  94,914 

18


Supplemental Reconciliation from Net Income to Adjusted EBITDA by Quarter - for the Year Ended December 31, 2022 - Unaudited
Three Months Ended Year Ended
March 31,
2022
June 30,
2022
September 30,
2022
December 31,
2022
December 31,
2022
(U.S. Dollars in thousands)
Net income (Reported GAAP) $ 3,409  $ 48,405  $ 46,580  $ 13,389  $ 111,783 
Loss from discontinued operations, net of income taxes 25,230  11,195  11,704  8,318  56,447 
Income from continuing operations (Reported GAAP) 28,639  59,600  58,284  21,707  168,230 
Income tax expense (benefit) 7,358  5,300  (34,155) (4,106) (25,603)
Interest expense 11,616  10,833  15,677  18,245  56,371 
Mark to market losses (gains) (1,138) (6,991) 2,310  8,868  3,049 
(Gain) on asset sales —  (7,816) (530) (1,970) (10,316)
Impairment on property, plant and equipment —  —  —  397  397 
Incremental charges on biological assets from the Acquisition 17,513  17,431  5,520  681  41,145 
Other items (868) 116  (532) 656  (628)
Adjustments from equity method investments 1,128  2,195  1,603  2,614  7,540 
Adjusted EBIT (Non-GAAP) 64,248  80,668  48,177  47,092  240,185 
Depreciation 22,533  25,696  25,315  25,159  98,703 
Amortization of intangible assets 2,842  2,773  2,633  2,645  10,893 
Depreciation and amortization adjustments from equity method investments 2,260  2,666  3,073  2,616  10,615 
Adjusted EBITDA (Non-GAAP) $ 91,883  $ 111,803  $ 79,198  $ 77,512  $ 360,396 

Supplemental Reconciliation from Net Income attributable to Dole plc to Adjusted Net Income by Quarter - for the Year Ended December 31, 2022 - Unaudited
Three Months Ended Year Ended
March 31,
2022
June 30,
2022
September 30,
2022
December 31,
2022
December 31,
2022
(U.S. Dollars and shares in thousands, except per share amounts)
Net income (loss) attributable to Dole plc (Reported GAAP) $ (1,394) $ 41,272  $ 39,837  $ 6,781  $ 86,496 
Loss from discontinued operations, net of income taxes 25,230  11,195  11,704  8,318  56,447 
Income from continuing operations attributable to Dole plc 23,836  52,467  51,541  15,099  142,943 
Adjustments:
Amortization of intangible assets 2,842  2,773  2,633  2,645  10,893 
Mark to market (gains) losses (1,138) (6,991) 2,310  8,868  3,049 
(Gain) on asset sales —  (7,816) (530) (1,970) (10,316)
Incremental charges on biological assets from the Acquisition 17,513  17,431  5,520  681  41,145 
Other items (868) 116  (532) 1,053  (231)
Adjustments from equity method investments 678  612  628  662  2,580 
 Income tax on items above and discrete tax items (1,931) (5,196) (34,501) (8,876) (50,504)
NCI impact on items above (458) (953) (878) (898) (3,187)
Adjusted Net Income for Adjusted EPS calculation (Non-GAAP) $ 40,474  $ 52,443  $ 26,191  $ 17,264  $ 136,372 
Adjusted earnings per share – basic (Non-GAAP) $ 0.43  $ 0.55  $ 0.28  $ 0.18  $ 1.44 
Adjusted earnings per share – diluted (Non-GAAP) $ 0.43  $ 0.55  $ 0.28  $ 0.18  $ 1.44 
Weighted average shares outstanding – basic 94,878  94,878  94,891  94,899  94,886 
Weighted average shares outstanding – diluted 94,909  94,913  94,908  94,928  94,914 
19




Supplemental Selected Segmental Financial Information by Quarter - for the Year Ended December 31, 2022 - Unaudited
Revenue by Segment:
Three Months Ended Year Ended
March 31,
2022
June 30,
2022
September 30,
2022
December 31,
2022
December 31,
2022
(U.S. Dollars in thousands)
Fresh Fruit $ 749,803  $ 805,831  $ 751,348  $ 740,167  $ 3,047,149 
Diversified Fresh Produce - EMEA 791,155  849,848  759,964  751,594  3,152,561 
Diversified Fresh Produce - Americas & ROW 463,692  448,200  479,839  573,936  1,965,667 
Intersegment (34,419) (52,970) (30,456) (23,129) (140,974)
Total $ 1,970,231  $ 2,050,909  $ 1,960,695  $ 2,042,568  $ 8,024,403 
Adjusted EBITDA by Segment:
Three Months Ended Year Ended
March 31,
2022
June 30,
2022
September 30,
2022
December 31,
2022
December 31,
2022
(U.S. Dollars in thousands)
Fresh Fruit $ 60,397  $ 56,308  $ 49,382  $ 39,460  $ 205,547 
Diversified Fresh Produce - EMEA 19,277  38,434  30,686  22,656  111,053 
Diversified Fresh Produce - Americas & ROW 12,209  17,061  (870) 15,396  43,796 
Total $ 91,883  $ 111,803  $ 79,198  $ 77,512  $ 360,396 
20


Non-GAAP Financial Measures
Dole plc’s results are determined in accordance with U.S. GAAP.
In addition to its results under U.S. GAAP, in this Press Release, we also present Dole plc’s Adjusted EBIT, Adjusted EBITDA, Adjusted Net Income, Adjusted EPS, Free Cash Flow from Continuing Operations and Net Debt, which are supplemental measures of financial performance that are not required by, or presented in accordance with, U.S. GAAP (collectively, the "non-GAAP financial measures"). We present these non-GAAP financial measures, because we believe they assist investors and analysts in comparing our operating performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. These non-GAAP financial measures have limitations as analytical tools, and you should not consider them in isolation or as a substitute for analysis of our operating results, cash flows or any other measure prescribed by U.S. GAAP. Our presentation of non-GAAP financial measures should not be construed as an inference that our future results will be unaffected by any of the adjusted items or that any projections and estimates will be realized in their entirety or at all. In addition, adjustment items that are excluded from non-GAAP results can have a material impact on equivalent GAAP earnings, financial measures and cash flows.
Adjusted EBIT is calculated from GAAP net income by: (1) adding the loss from discontinued operations, net of income taxes; (2) adding the income tax expense or subtracting the income tax benefit; (3) adding interest expense; (4) adding mark to market losses or subtracting mark to market gains related to unrealized impacts from derivative instruments and foreign currency denominated borrowings, realized impacts on noncash settled foreign currency denominated borrowings, net foreign currency impacts on liquidated entities and fair value movements on contingent consideration; (5) other items which are separately stated based on materiality, which during the three and nine months ended September 30, 2023 and September 30, 2022, included adding or subtracting asset write-downs from extraordinary events, net of insurance proceeds, subtracting the gain or adding the loss on the disposal of business interests, adding the incremental costs from the fair value uplift for biological assets related to the acquisition of Legacy Dole, subtracting the gain or adding the loss on the sale of investments accounted for under the equity method, subtracting the gain or adding the loss on asset sales for assets held for sale and actively marketed property, adding restructuring charges and costs for legal matters not in the ordinary course of business and adding costs incurred for the cyber-related incident; and (6) the Company’s share of these items from equity method investments.

Adjusted EBITDA is calculated from GAAP net income by: (1) adding the loss from discontinued operations, net of income taxes; (2) adding the income tax expense or subtracting the income tax benefit; (3) adding interest expense; (4) adding depreciation charges; (5) adding amortization charges on intangible assets; (6) adding mark to market losses or subtracting mark to market gains related to unrealized impacts from derivative instruments and foreign currency denominated borrowings, realized impacts on noncash settled foreign currency denominated borrowings, net foreign currency impacts on liquidated entities and fair value movements on contingent consideration; (7) other items which are separately stated based on materiality, which during the three and nine months ended September 30, 2023 and September 30, 2022, included adding or subtracting asset write-downs from extraordinary events, net of insurance proceeds, subtracting the gain or adding the loss on the disposal of business interests, adding the incremental costs from the fair value uplift for biological assets related to the acquisition of Legacy Dole, subtracting the gain or adding the loss on the sale of investments accounted for under the equity method, subtracting the gain or adding the loss on asset sales for assets held for sale and actively marketed property, adding restructuring charges and costs for legal matters not in the ordinary course of business and adding costs incurred for the cyber-related incident; and (8) the Company’s share of these items from equity method investments.
Adjusted Net Income is calculated from GAAP net income attributable to Dole plc by: (1) adding the loss from discontinued operations, net of income taxes; (2) adding amortization charges on intangible assets; (3) adding mark to market losses or subtracting mark to market gains related to unrealized impacts from derivative instruments and foreign currency denominated borrowings, realized impacts on noncash settled foreign currency denominated borrowings, net foreign currency impacts on liquidated entities and fair value movements on contingent consideration; (4) other items which are separately stated based on materiality, which during the three and nine months ended September 30, 2023 and September 30, 2022, included adding or subtracting asset write-downs from extraordinary events, net of insurance proceeds, subtracting the gain or adding the loss on the disposal of business interests, adding the incremental costs from the fair value uplift for biological assets related to the acquisition of Legacy Dole, subtracting the gain or adding the loss on the sale of investments accounted for under the equity method, subtracting the gain or adding the loss on asset sales for assets held for sale and actively marketed property, adding restructuring charges and costs for legal matters not in the ordinary course of business and adding costs incurred for the cyber-related incident; (5) the Company’s share of these items from equity method investments; (6) excluding the tax effect of these items and discrete tax adjustments; and (7) excluding the effect of these items attributable to non-controlling interests.
Adjusted Earnings per Share is calculated from Adjusted Net Income divided by diluted weighted average number of shares in the applicable period.
Net Debt is a non-GAAP financial measure, calculated as GAAP cash and cash equivalents, less GAAP current and long-term debt. It also excludes GAAP unamortized debt discounts and debt issuance costs.
Free cash flow from continuing operations is calculated from GAAP net cash provided by operating activities for continuing operations less GAAP capital expenditures.
Like-for-like basis refers to the U.S. GAAP measure or non-GAAP financial measure excluding the impact of foreign currency translation movements and acquisitions and divestitures.
Dole is not able to provide a reconciliation for projected FY'23 results without taking unreasonable efforts.
21